HIF1-Alpha Expression Predicts Survival of Patients with Squamous Cell Carcinoma of the Oral Cavity

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Santos, Marcelo dos ^a,b   Mercante, Ana Maria da Cunha ^b   Louro, Iúri Drumond ^c   Gonçalves, Antônio José ^a   Carvalho, Marcos Brasilino de ^b   da Silva, Eloiza Helena Tajara ^d   da Silva, Adriana Madeira Álvares ^c  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b HOSPITAL HELIÓPOLIS   (Brazil)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^d FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVESSEL DENSITY; MOUTH SQUAMOUS CELL CARCINOMA; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; POSTOPERATIVE CARE; POSTOPERATIVE RADIOTHERAPY; PROTEIN EXPRESSION; SURVIVAL PREDICTION; TISSUE MICROARRAY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866484004     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045228     Document Type: Article

References (56)

1. Bauman JE, Michel LS, Chung CH, (2012) New promising molecular targets in head and neck squamous cell carcinoma. Curr Opin Oncol 24(3): 235-242.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer: Available: http://globocan.iarc.fr. Accessed 20 July 2012.
3. Myers EM, Fagan JJ, (1998) Treatment of the N+ neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Clin North Am 31(4): 671-686.
4. Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, et al. (2004) The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck 26(8): 660-674.
5. Pentenero M, Gandolfo S, Carrozzo M, (2005) Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 27: 1080-1091.
6. Bunn HF, Poyton RO, (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76: 839-885.
7. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, et al. (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94: 8104-8109.
8. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, et al. (1999) Overexpression of hypoxia-inducible factor 1a in common human cancers and their metastases. Cancer Res 59: 5830-5835.
9. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, et al. (2000) Hypoxia-inducible factor-1a is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015.
10. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, et al. (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumorassociated macrophages. Am J Pathol 157: 411-421.
11. Giordano FJ, Johnson RS, (2001) Angiogenesis: the role of the microenvironment in flipping the switch. Curr Opin Genet Dev 11: 35-40.
12. Semenza GL, (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8: S62-67.
13. Brizel DM, Dodge RK, Clough RW, Dewhirst MW, (1999) Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53: 113-117.
14. Kolstad P, (1968) Intercapillary Distance, Oxygen Tension and Local Recurrence in Cervix Cancer. Scand. J Clin Lab 21(106): 145-157.
15. Nordsmark M, Overgaard J, (2000) A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radio Oncol 57(1): 39-43.
16. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, et al. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12: 149-162.
17. Semenza GL, (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578.
18. Bruick RK, McKnight SL, (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340.
19. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rouke J, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54.
20. Ivan M, Kondo K, Yang H, Kim W, Valiando J, et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292(5516): 464-468.
21. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292(5516): 468-472.
22. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ, (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. Eur Mol Biol Organ J 20: 5197-5206.
23. Bruick RK, (2003) Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev 17(21): 2614-2623.
24. Huang LE, Bunn HF, (2003) Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 278(22): 19575-19578.
25. Semenza GL, (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10): 721-732.
26. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL, (2000) Relationship of hypoxia-inducible factor (HIF)-1a and HIF-2a expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 60: 7106-7113.
27. Ratcliffe PJ, Pugh CW, Maxwell PH, (2000) Targeting tumors through the HIF system. Nat Med 6: 1315-1316.
28. Rice C. Huang LE, (2011) From antiangiogenesis to hypoxia: current research and future directions. Cancer Man Res 3: 9-16.
29. Na X, Wu G, Ryan CK, Schoen SR, di'Santagnese PA, et al. (2003) Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1a expression in renal cell carcinomas. J Urol 170: 588-592.
30. Theodoropoulos VE, Lazaris AC, Sofras F, Gerzelis I, Tsoukala V, et al. (2004) Hypoxia-inducible factor 1a expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46: 200-208.
31. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, et al. (2003) Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105(2): 176-181.
32. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, et al. (2002) Overexpression of hypoxia-inducible factor 1a is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8: 1831-1837.
33. Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, et al. (2003) Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97(6): 1573-1581.
34. Nakayama K, Kanzaki A, Hata K, Katabuchi H, Okamura H, et al. (2002) Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett 176(2): 215-223.
35. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, et al. (2000) Overexpression of hypoxia-inducible factor 1a is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60: 4693-4696.
36. Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, et al. (2003) Significant correlation of hypoxia-inducible factor-1a with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Rad Oncol Biol Phys 56: 494-501.
37. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, et al. (2002) Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 62: 2493-2497.
38. Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U, et al. (2005) HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 5: 84.
39. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, et al. (2001) Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61(7): 2911-2916.
40. Éric C, (2005) Hypoxia-inducible factor 1: regulation, involvement in carcinogenesis and target for anticancer therapy. Bull Cancer 92(2): 119-127.
41. Deschler DG, Day T (2008) Pocket Guide to Neck Dissection and Classification and TNM Staging of Head and Neck Cancer. American Academy of Otolaryngology-Head and Neck Surgery Foundation. 28 p.
42. Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, et al. (2001) Tisse microarray: a new technology for amplification of tissue resources. Cancer J 7(1): 24-31.
43. Hedvat CV, Hedge A, Chaganti RS, Chen B, Qin J, et al. (2002) Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. Hum Pathol 33(10): 968-974.
44. Hsu SM, Raine L, Fanger H, (2002) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75(6): 816-821.
45. Soini Y, Kahlos K, Punhkka A, Lakari E, Säily M, et al. (2000) Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma. Brit J Cancer 83(7): 880-886.
46. Campos AH, Aldred VL, Ribeiro KC, Vassallo J, Soares FA, (2009) Role of immunoexpression of nitric oxide synthases by Hodgkin and Reed-Sternberg cells on apoptosis deregulation and on clinical outcome of classical Hodgkin lymphoma. Mol Cell Biochem 321(1-2): 95-102.
47. Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, et al. (2008) Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 37(1): 18-25.
48. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, et al. (2002) Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 53(5): 1192-1202.
49. Koukourakis MI, Giatromanolaki A, Danielidis V, Sivridis E, (2008) Hypoxia inducible factor (HIF1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. Int J Radiat Biol 84(1): 47-52.
50. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, et al. (2002) Expression of hypoxia-inducible factor-1α and-2α in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13(7): 1721-1732.
51. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, et al. (2006) Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell 10(5): 413-423.
52. Astekar M, Joshi A, Ramesh G, Metgud R, (2012) Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis. J Oral Maxillofac Pathol. 16(1): 22-26.
53. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, et al. (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838.
54. Tomida A, Tsuruo T, (1999) Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des 14: 169-177.
55. Zölzer F, Streffer C, (2002) Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. Int J Radiat Oncol Biol Phys 54(3): 910-920.
56. Lagerlöf JH, Kindblom J, Bernhardt P, (2011) 3D modeling of effects of increased oxygenation and activity concentration in tumors treated with radionuclides and antiangiogenic drugs. Med Phys 38(8): 4888-4893.